ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

Promotions at MSKCC: Fuks heads radiation oncology, Pfister named chief of Head & Neck Medical Oncology Service.

October 15, 2004

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995